Global Fragment-based Drug Discovery Market Research Report 2026(Status and Outlook)

March 2026 | 149 pages | ID: GD55ADA25361EN
Bosson Research

Abstracts

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Fragment-based Drug Discovery market size was estimated at USD 387.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Fragment-based Drug Discovery market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Fragment-based Drug Discovery market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Fragment-based Drug Discovery market.

Global Fragment-based Drug Discovery Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery

Market Segmentation (by Type)

Fragment Screening
Fragment Optimization

Market Segmentation (by Application)

Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Fragment-based Drug Discovery Market
Overview of the regional outlook of the Fragment-based Drug Discovery Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Fragment-based Drug Discovery Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Fragment-based Drug Discovery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Fragment-based Drug Discovery
1.2 Key Market Segments
  1.2.1 Fragment-based Drug Discovery Segment by Type
  1.2.2 Fragment-based Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 FRAGMENT-BASED DRUG DISCOVERY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Fragment-based Drug Discovery Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Fragment-based Drug Discovery Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 FRAGMENT-BASED DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Fragment-based Drug Discovery Product Life Cycle
3.3 Global Fragment-based Drug Discovery Sales by Manufacturers (2020-2025)
3.4 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2020-2025)
3.5 Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Fragment-based Drug Discovery Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Fragment-based Drug Discovery Market Competitive Situation and Trends
  3.8.1 Fragment-based Drug Discovery Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Fragment-based Drug Discovery Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 FRAGMENT-BASED DRUG DISCOVERY INDUSTRY CHAIN ANALYSIS

4.1 Fragment-based Drug Discovery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF FRAGMENT-BASED DRUG DISCOVERY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Fragment-based Drug Discovery Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Fragment-based Drug Discovery Market
5.7 ESG Ratings of Leading Companies

6 FRAGMENT-BASED DRUG DISCOVERY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Fragment-based Drug Discovery Sales Market Share by Type (2020-2025)
6.3 Global Fragment-based Drug Discovery Market Size by Type (2020-2025)
6.4 Global Fragment-based Drug Discovery Price by Type (2020-2025)

7 FRAGMENT-BASED DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Fragment-based Drug Discovery Market Sales by Application (2020-2025)
7.3 Global Fragment-based Drug Discovery Market Size (M USD) by Application (2020-2025)
7.4 Global Fragment-based Drug Discovery Sales Growth Rate by Application (2020-2025)

8 FRAGMENT-BASED DRUG DISCOVERY MARKET SALES BY REGION

8.1 Global Fragment-based Drug Discovery Sales by Region
  8.1.1 Global Fragment-based Drug Discovery Sales by Region
  8.1.2 Global Fragment-based Drug Discovery Sales Market Share by Region
8.2 Global Fragment-based Drug Discovery Market Size by Region
  8.2.1 Global Fragment-based Drug Discovery Market Size by Region
  8.2.2 Global Fragment-based Drug Discovery Market Size by Region
8.3 North America
  8.3.1 North America Fragment-based Drug Discovery Sales by Country
  8.3.2 North America Fragment-based Drug Discovery Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Fragment-based Drug Discovery Sales by Country
  8.4.2 Europe Fragment-based Drug Discovery Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Fragment-based Drug Discovery Sales by Region
  8.5.2 Asia Pacific Fragment-based Drug Discovery Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Fragment-based Drug Discovery Sales by Country
  8.6.2 South America Fragment-based Drug Discovery Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Fragment-based Drug Discovery Sales by Region
  8.7.2 Middle East and Africa Fragment-based Drug Discovery Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 FRAGMENT-BASED DRUG DISCOVERY MARKET PRODUCTION BY REGION

9.1 Global Production of Fragment-based Drug Discovery by Region(2020-2025)
9.2 Global Fragment-based Drug Discovery Revenue Market Share by Region (2020-2025)
9.3 Global Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Fragment-based Drug Discovery Production
  9.4.1 North America Fragment-based Drug Discovery Production Growth Rate (2020-2025)
  9.4.2 North America Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Fragment-based Drug Discovery Production
  9.5.1 Europe Fragment-based Drug Discovery Production Growth Rate (2020-2025)
  9.5.2 Europe Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Fragment-based Drug Discovery Production (2020-2025)
  9.6.1 Japan Fragment-based Drug Discovery Production Growth Rate (2020-2025)
  9.6.2 Japan Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Fragment-based Drug Discovery Production (2020-2025)
  9.7.1 China Fragment-based Drug Discovery Production Growth Rate (2020-2025)
  9.7.2 China Fragment-based Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Astex Pharmaceuticals
  10.1.1 Astex Pharmaceuticals Basic Information
  10.1.2 Astex Pharmaceuticals Fragment-based Drug Discovery Product Overview
  10.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Product Market Performance
  10.1.4 Astex Pharmaceuticals Business Overview
  10.1.5 Astex Pharmaceuticals SWOT Analysis
  10.1.6 Astex Pharmaceuticals Recent Developments
10.2 Alveus Pharmaceuticals
  10.2.1 Alveus Pharmaceuticals Basic Information
  10.2.2 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Overview
  10.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Market Performance
  10.2.4 Alveus Pharmaceuticals Business Overview
  10.2.5 Alveus Pharmaceuticals SWOT Analysis
  10.2.6 Alveus Pharmaceuticals Recent Developments
10.3 Beactica
  10.3.1 Beactica Basic Information
  10.3.2 Beactica Fragment-based Drug Discovery Product Overview
  10.3.3 Beactica Fragment-based Drug Discovery Product Market Performance
  10.3.4 Beactica Business Overview
  10.3.5 Beactica SWOT Analysis
  10.3.6 Beactica Recent Developments
10.4 Charles River Laboratories
  10.4.1 Charles River Laboratories Basic Information
  10.4.2 Charles River Laboratories Fragment-based Drug Discovery Product Overview
  10.4.3 Charles River Laboratories Fragment-based Drug Discovery Product Market Performance
  10.4.4 Charles River Laboratories Business Overview
  10.4.5 Charles River Laboratories Recent Developments
10.5 Crown Bioscience
  10.5.1 Crown Bioscience Basic Information
  10.5.2 Crown Bioscience Fragment-based Drug Discovery Product Overview
  10.5.3 Crown Bioscience Fragment-based Drug Discovery Product Market Performance
  10.5.4 Crown Bioscience Business Overview
  10.5.5 Crown Bioscience Recent Developments
10.6 Emerald BioStructures
  10.6.1 Emerald BioStructures Basic Information
  10.6.2 Emerald BioStructures Fragment-based Drug Discovery Product Overview
  10.6.3 Emerald BioStructures Fragment-based Drug Discovery Product Market Performance
  10.6.4 Emerald BioStructures Business Overview
  10.6.5 Emerald BioStructures Recent Developments
10.7 Evotec
  10.7.1 Evotec Basic Information
  10.7.2 Evotec Fragment-based Drug Discovery Product Overview
  10.7.3 Evotec Fragment-based Drug Discovery Product Market Performance
  10.7.4 Evotec Business Overview
  10.7.5 Evotec Recent Developments
10.8 Kinetic Discovery
  10.8.1 Kinetic Discovery Basic Information
  10.8.2 Kinetic Discovery Fragment-based Drug Discovery Product Overview
  10.8.3 Kinetic Discovery Fragment-based Drug Discovery Product Market Performance
  10.8.4 Kinetic Discovery Business Overview
  10.8.5 Kinetic Discovery Recent Developments
10.9 Proteros Fragments
  10.9.1 Proteros Fragments Basic Information
  10.9.2 Proteros Fragments Fragment-based Drug Discovery Product Overview
  10.9.3 Proteros Fragments Fragment-based Drug Discovery Product Market Performance
  10.9.4 Proteros Fragments Business Overview
  10.9.5 Proteros Fragments Recent Developments
10.10 Sprint Bioscience
  10.10.1 Sprint Bioscience Basic Information
  10.10.2 Sprint Bioscience Fragment-based Drug Discovery Product Overview
  10.10.3 Sprint Bioscience Fragment-based Drug Discovery Product Market Performance
  10.10.4 Sprint Bioscience Business Overview
  10.10.5 Sprint Bioscience Recent Developments
10.11 Structure Based Design
  10.11.1 Structure Based Design Basic Information
  10.11.2 Structure Based Design Fragment-based Drug Discovery Product Overview
  10.11.3 Structure Based Design Fragment-based Drug Discovery Product Market Performance
  10.11.4 Structure Based Design Business Overview
  10.11.5 Structure Based Design Recent Developments
10.12 Sygnature Discovery
  10.12.1 Sygnature Discovery Basic Information
  10.12.2 Sygnature Discovery Fragment-based Drug Discovery Product Overview
  10.12.3 Sygnature Discovery Fragment-based Drug Discovery Product Market Performance
  10.12.4 Sygnature Discovery Business Overview
  10.12.5 Sygnature Discovery Recent Developments

11 FRAGMENT-BASED DRUG DISCOVERY MARKET FORECAST BY REGION

11.1 Global Fragment-based Drug Discovery Market Size Forecast
11.2 Global Fragment-based Drug Discovery Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Fragment-based Drug Discovery Market Size Forecast by Country
  11.2.3 Asia Pacific Fragment-based Drug Discovery Market Size Forecast by Region
  11.2.4 South America Fragment-based Drug Discovery Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Fragment-based Drug Discovery by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Fragment-based Drug Discovery Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Fragment-based Drug Discovery by Type (2026-2035)
  12.1.2 Global Fragment-based Drug Discovery Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Fragment-based Drug Discovery by Type (2026-2035)
12.2 Global Fragment-based Drug Discovery Market Forecast by Application (2026-2035)
  12.2.1 Global Fragment-based Drug Discovery Sales (K Units) Forecast by Application
  12.2.2 Global Fragment-based Drug Discovery Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Fragment-based Drug Discovery Market Size by Type (M USD)
Table 4. Global Fragment-based Drug Discovery Market Size by Application
Table 5. Fragment-based Drug Discovery Market Size Comparison by Region (M USD)
Table 6. Global Fragment-based Drug Discovery Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Fragment-based Drug Discovery Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Fragment-based Drug Discovery Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Fragment-based Drug Discovery Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2025)
Table 11. Global Market Fragment-based Drug Discovery Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Fragment-based Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Fragment-based Drug Discovery Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Fragment-based Drug Discovery Sales by Type (K Units)
Table 27. Global Fragment-based Drug Discovery Market Size by Type (M USD)
Table 28. Global Fragment-based Drug Discovery Sales (K Units) by Type (2020-2025)
Table 29. Global Fragment-based Drug Discovery Sales Market Share by Type (2020-2025)
Table 30. Global Fragment-based Drug Discovery Market Size (M USD) by Type (2020-2025)
Table 31. Global Fragment-based Drug Discovery Market Share by Type (2020-2025)
Table 32. Global Fragment-based Drug Discovery Price (USD/Unit) by Type (2020-2025)
Table 33. Global Fragment-based Drug Discovery Sales (K Units) by Application
Table 34. Global Fragment-based Drug Discovery Market Size by Application
Table 35. Global Fragment-based Drug Discovery Sales by Application (2020-2025) & (K Units)
Table 36. Global Fragment-based Drug Discovery Sales Market Share by Application (2020-2025)
Table 37. Global Fragment-based Drug Discovery Market Size by Application (2020-2025) & (M USD)
Table 38. Global Fragment-based Drug Discovery Market Share by Application (2020-2025)
Table 39. Global Fragment-based Drug Discovery Sales Growth Rate by Application (2020-2025)
Table 40. Global Fragment-based Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 41. Global Fragment-based Drug Discovery Sales Market Share by Region (2020-2025)
Table 42. Global Fragment-based Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 43. Global Fragment-based Drug Discovery Market Size by Region (2020-2025)
Table 44. North America Fragment-based Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 45. North America Fragment-based Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Fragment-based Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 47. Europe Fragment-based Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Fragment-based Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Fragment-based Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 50. South America Fragment-based Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 51. South America Fragment-based Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Fragment-based Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Fragment-based Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 54. Global Fragment-based Drug Discovery Production (K Units) by Region(2020-2025)
Table 55. Global Fragment-based Drug Discovery Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Fragment-based Drug Discovery Revenue Market Share by Region (2020-2025)
Table 57. Global Fragment-based Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Fragment-based Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Fragment-based Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Fragment-based Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Fragment-based Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Astex Pharmaceuticals Basic Information
Table 63. Astex Pharmaceuticals Fragment-based Drug Discovery Product Overview
Table 64. Astex Pharmaceuticals Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Astex Pharmaceuticals Business Overview
Table 66. Astex Pharmaceuticals SWOT Analysis
Table 67. Astex Pharmaceuticals Recent Developments
Table 68. Alveus Pharmaceuticals Basic Information
Table 69. Alveus Pharmaceuticals Fragment-based Drug Discovery Product Overview
Table 70. Alveus Pharmaceuticals Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Alveus Pharmaceuticals Business Overview
Table 72. Alveus Pharmaceuticals SWOT Analysis
Table 73. Alveus Pharmaceuticals Recent Developments
Table 74. Beactica Basic Information
Table 75. Beactica Fragment-based Drug Discovery Product Overview
Table 76. Beactica Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Beactica Business Overview
Table 78. Beactica SWOT Analysis
Table 79. Beactica Recent Developments
Table 80. Charles River Laboratories Basic Information
Table 81. Charles River Laboratories Fragment-based Drug Discovery Product Overview
Table 82. Charles River Laboratories Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Charles River Laboratories Business Overview
Table 84. Charles River Laboratories Recent Developments
Table 85. Crown Bioscience Basic Information
Table 86. Crown Bioscience Fragment-based Drug Discovery Product Overview
Table 87. Crown Bioscience Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Crown Bioscience Business Overview
Table 89. Crown Bioscience Recent Developments
Table 90. Emerald BioStructures Basic Information
Table 91. Emerald BioStructures Fragment-based Drug Discovery Product Overview
Table 92. Emerald BioStructures Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Emerald BioStructures Business Overview
Table 94. Emerald BioStructures Recent Developments
Table 95. Evotec Basic Information
Table 96. Evotec Fragment-based Drug Discovery Product Overview
Table 97. Evotec Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Evotec Business Overview
Table 99. Evotec Recent Developments
Table 100. Kinetic Discovery Basic Information
Table 101. Kinetic Discovery Fragment-based Drug Discovery Product Overview
Table 102. Kinetic Discovery Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Kinetic Discovery Business Overview
Table 104. Kinetic Discovery Recent Developments
Table 105. Proteros Fragments Basic Information
Table 106. Proteros Fragments Fragment-based Drug Discovery Product Overview
Table 107. Proteros Fragments Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Proteros Fragments Business Overview
Table 109. Proteros Fragments Recent Developments
Table 110. Sprint Bioscience Basic Information
Table 111. Sprint Bioscience Fragment-based Drug Discovery Product Overview
Table 112. Sprint Bioscience Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sprint Bioscience Business Overview
Table 114. Sprint Bioscience Recent Developments
Table 115. Structure Based Design Basic Information
Table 116. Structure Based Design Fragment-based Drug Discovery Product Overview
Table 117. Structure Based Design Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Structure Based Design Business Overview
Table 119. Structure Based Design Recent Developments
Table 120. Sygnature Discovery Basic Information
Table 121. Sygnature Discovery Fragment-based Drug Discovery Product Overview
Table 122. Sygnature Discovery Fragment-based Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sygnature Discovery Business Overview
Table 124. Sygnature Discovery Recent Developments
Table 125. Global Fragment-based Drug Discovery Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Fragment-based Drug Discovery Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Fragment-based Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Fragment-based Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Fragment-based Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Fragment-based Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Fragment-based Drug Discovery Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Fragment-based Drug Discovery Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Fragment-based Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Fragment-based Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Fragment-based Drug Discovery Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Fragment-based Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Fragment-based Drug Discovery Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Fragment-based Drug Discovery Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Fragment-based Drug Discovery Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Fragment-based Drug Discovery Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Fragment-based Drug Discovery Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Fragment-based Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Fragment-based Drug Discovery Market Size (M USD), 2025-2035
Figure 5. Global Fragment-based Drug Discovery Market Size (M USD) (2020-2035)
Figure 6. Global Fragment-based Drug Discovery Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Fragment-based Drug Discovery Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Fragment-based Drug Discovery Product Life Cycle
Figure 13. Fragment-based Drug Discovery Sales Share by Manufacturers in 2025
Figure 14. Global Fragment-based Drug Discovery Revenue Share by Manufacturers in 2025
Figure 15. Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Fragment-based Drug Discovery Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Fragment-based Drug Discovery Revenue in 2025
Figure 18. Industry Chain Map of Fragment-based Drug Discovery
Figure 19. Global Fragment-based Drug Discovery Market PEST Analysis
Figure 20. Global Fragment-based Drug Discovery Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Fragment-based Drug Discovery Market Share by Type
Figure 27. Sales Market Share of Fragment-based Drug Discovery by Type (2020-2025)
Figure 28. Sales Market Share of Fragment-based Drug Discovery by Type in 2025
Figure 29. Market Share of Fragment-based Drug Discovery by Type (2020-2025)
Figure 30. Market Share of Fragment-based Drug Discovery by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Fragment-based Drug Discovery Market Share by Application
Figure 33. Global Fragment-based Drug Discovery Sales Market Share by Application (2020-2025)
Figure 34. Global Fragment-based Drug Discovery Sales Market Share by Application in 2025
Figure 35. Global Fragment-based Drug Discovery Market Share by Application (2020-2025)
Figure 36. Global Fragment-based Drug Discovery Market Share by Application in 2025
Figure 37. Global Fragment-based Drug Discovery Sales Growth Rate by Application (2020-2025)
Figure 38. Global Fragment-based Drug Discovery Sales Market Share by Region (2020-2025)
Figure 39. Global Fragment-based Drug Discovery Market Size by Region (2020-2025)
Figure 40. North America Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Fragment-based Drug Discovery Sales Market Share by Country in 2024
Figure 43. North America Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Fragment-based Drug Discovery Market Size by Country in 2024
Figure 45. U.S. Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Fragment-based Drug Discovery Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Fragment-based Drug Discovery Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Fragment-based Drug Discovery Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Fragment-based Drug Discovery Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Fragment-based Drug Discovery Sales Market Share by Country in 2024
Figure 53. Europe Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Fragment-based Drug Discovery Market Size by Country in 2024
Figure 55. Germany Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Fragment-based Drug Discovery Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Fragment-based Drug Discovery Sales Market Share by Region in 2024
Figure 67. Asia Pacific Fragment-based Drug Discovery Market Size by Region in 2024
Figure 68. China Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Fragment-based Drug Discovery Sales and Growth Rate (K Units)
Figure 79. South America Fragment-based Drug Discovery Sales Market Share by Country in 2024
Figure 80. South America Fragment-based Drug Discovery Market Size and Growth Rate (M USD)
Figure 81. South America Fragment-based Drug Discovery Market Size by Country in 2024
Figure 82. Brazil Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Fragment-based Drug Discovery Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Fragment-based Drug Discovery Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Fragment-based Drug Discovery Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Fragment-based Drug Discovery Market Size by Region in 2024
Figure 92. Saudi Arabia Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Fragment-based Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Fragment-based Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Fragment-based Drug Discovery Production Market Share by Region (2020-2025)
Figure 103. North America Fragment-based Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Fragment-based Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Fragment-based Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 106. China Fragment-based Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Fragment-based Drug Discovery Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Fragment-based Drug Discovery Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Fragment-based Drug Discovery Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Fragment-based Drug Discovery Market Share Forecast by Type (2026-2035)
Figure 111. Global Fragment-based Drug Discovery Sales Forecast by Application (2026-2035)
Figure 112. Global Fragment-based Drug Discovery Market Share Forecast by Application (2026-2035)